‘Small Pharma Was Established to Make Medicine’ – Peter Rands, Director and CEO скачать в хорошем качестве

‘Small Pharma Was Established to Make Medicine’ – Peter Rands, Director and CEO

Investors in the psychedelics space may have only just heard of the UK-based Small Pharma (TSXV: DMT.V OTC: DMTTF). The company was listed on the TSX Venture a short 5 weeks ago. We’re pleased to welcome to The Dales Report Peter Rands, the Director and CEO of Small Pharma to discuss his company and their focus on DMT. Here’s some highlights from the interview: Small Pharma portfolio largely in tryptamines and psychedelic tryptamines Small Pharma has an asset in Rands and his background in patent law Rands clarifies for investors: Small Pharma is focused on DMT, not 5-methoxy DMT The world’s leading institutes for developing psychedelic-assisted medicine based in London About Channel: We are a business news platform that provides the latest and best insight on the stories making headlines around the world. We give Institutional and retail investors an inside edge in the competitive world of investing and profile companies that are making waves in their ever-growing industries. We are The Dales Report. Check out our website: https://thedalesreport.com/​​ Subscribe to our channel at https://article.thedalesreport.com/yo... Connect with us on our social media handles: Twitter:   / thedalesreport​​   Instagram:   / thedalesrep...​   Tiktok:   / thedalesrepor...​   Facebook:   / thedalesreport​